Literature DB >> 29236290

An 8-generation family with X-linked Charcot-Marie-Tooth: Confirmation Of the pathogenicity Of a 3' untranslated region mutation in GJB1 and its clinical features.

Dong-Hui Chen1, Maxwell Ma1,2, Mena Scavina3, Elizabeth Blue4, John Wolff4,5, Prasanthi Karna4, Michael O Dorschner6,7, Wendy H Raskind4,5, Thomas D Bird1,4,5.   

Abstract

INTRODUCTION: Mutations in gap junction protein beta 1 (GJB1) on the X chromosome represent one of the most common causes of hereditary neuropathy. We assessed manifestations associated with a rare 3' untranslated region mutation (UTR) of GJB1 in a large family with X-linked Charcot-Marie-Tooth disease (CMTX).
METHODS: Clinical, electrophysiological, and molecular genetic analyses were performed on an 8-generation family with CMTX.
RESULTS: There were 22 affected males and 19 symptomatic females, including an 83-year-old woman followed for 40 years. Electrophysiological studies showed a primarily axonal neuropathy. The c.*15C>T mutation in the GJB1 3' UTR was identified in 4 branches of the family with a log of odds (LOD) of 4.91. This created a BstE II enzyme recognition site that enabled detection by restriction digestion. DISCUSSION: The c.*15C>T mutation in the GJB1 3' UTR segregates with CMTX1 in 8 generations. Penetrance in males and females is essentially complete. A straightforward genetic method to detect this mutation is described. Muscle Nerve 57: 859-862, 2018.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  CMTX; Charcot-Marie-Tooth; Connexin-32; GJB1; Neuropathy; X-linked

Mesh:

Substances:

Year:  2017        PMID: 29236290      PMCID: PMC5910283          DOI: 10.1002/mus.26037

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  15 in total

Review 1.  The role of the 3' untranslated region in post-transcriptional regulation of protein expression in mammalian cells.

Authors:  Eva Matoulkova; Eva Michalova; Borivoj Vojtesek; Roman Hrstka
Journal:  RNA Biol       Date:  2012-05-01       Impact factor: 4.652

2.  Clinical characterization and genetic analysis of Korean patients with X-linked Charcot-Marie-Tooth disease type 1.

Authors:  Young B Hong; Jin-Mo Park; Jin S Yu; Da H Yoo; Da E Nam; Hyung J Park; Ji-Su Lee; Sun H Hwang; Ki W Chung; Byung-Ok Choi
Journal:  J Peripher Nerv Syst       Date:  2017-09       Impact factor: 3.494

Review 3.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

Review 4.  GJB1-associated X-linked Charcot-Marie-Tooth disease, a disorder affecting the central and peripheral nervous systems.

Authors:  Charles K Abrams; Mona Freidin
Journal:  Cell Tissue Res       Date:  2014-11-05       Impact factor: 5.249

5.  CMT1X phenotypes represent loss of GJB1 gene function.

Authors:  M E Shy; C Siskind; E R Swan; K M Krajewski; T Doherty; D R Fuerst; P J Ainsworth; R A Lewis; S S Scherer; A F Hahn
Journal:  Neurology       Date:  2007-03-13       Impact factor: 9.910

Review 6.  A Review of X-linked Charcot-Marie-Tooth Disease.

Authors:  Ying Wang; Fei Yin
Journal:  J Child Neurol       Date:  2015-09-18       Impact factor: 1.987

Review 7.  How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?

Authors:  Kleopas A Kleopa; Charles K Abrams; Steven S Scherer
Journal:  Brain Res       Date:  2012-07-06       Impact factor: 3.252

8.  Clinical and Genetic Features of Chinese X-linked Charcot-Marie-Tooth Type 1 Disease.

Authors:  Yuan-Yuan Lu; He Lyu; Su-Qin Jin; Yue-Huan Zuo; Jing Liu; Zhao-Xia Wang; Wei Zhang; Yun Yuan
Journal:  Chin Med J (Engl)       Date:  2017-05-05       Impact factor: 2.628

9.  Mutations in noncoding regions of GJB1 are a major cause of X-linked CMT.

Authors:  Pedro J Tomaselli; Alexander M Rossor; Alejandro Horga; Zane Jaunmuktane; Aisling Carr; Paola Saveri; Giuseppe Piscosquito; Davide Pareyson; Matilde Laura; Julian C Blake; Roy Poh; James Polke; Henry Houlden; Mary M Reilly
Journal:  Neurology       Date:  2017-03-10       Impact factor: 9.910

Review 10.  Clinical implications of genetic advances in Charcot-Marie-Tooth disease.

Authors:  Alexander M Rossor; James M Polke; Henry Houlden; Mary M Reilly
Journal:  Nat Rev Neurol       Date:  2013-09-10       Impact factor: 42.937

View more
  2 in total

Review 1.  Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges.

Authors:  Menelaos Pipis; Alexander M Rossor; Matilde Laura; Mary M Reilly
Journal:  Nat Rev Neurol       Date:  2019-10-03       Impact factor: 42.937

Review 2.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.